Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer.

Saved in:
Bibliographic Details
Title: Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer.
Authors: Bouche O; CHU Reims, Reims, France. obouche@chu-reims.fr, Maindrault-Goebel F, Ducreux M, Lledo G, Andre T, Stopfer P, Amellal N, Merger M, De Gramont A
Source: Anticancer research [Anticancer Res] 2011 Jun; Vol. 31 (6), pp. 2271-81.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7530